(firstQuint)Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks.

 A consecutive case series of patients with angioid streaks that developed subfoveal choroidal neovascularization were treated with a primary 2.

5 mg injection of Bevacizumab (Avastin) intravitreally.

 All patients were evaluated with BCVA at 1, 2 , 4 and 12 weeks and OCT and fluoresceine angiography at month 1 and 3.

 (Patients will be follow 6 months).

 Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks@highlight

Intravitreal Bevacizumab is an effective treatment for choroidal neovascularization secondary to Angioid Streaks